TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. RISING LOAD OF DERMATOLOGY DISEASES
3.2.2. RISE IN AWARENESS LEVELS OF DISEASE PROGRESSION AND ORIGIN
3.3. KEY RESTRAINTS
3.3.1. SEVERE SIDE EFFECTS OF CERTAIN CLASSES OF THERAPEUTIC DRUGS
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
5. MARKET BY DRUG CLASS
5.1. ANTI-INFECTIVES
5.2. CORTICOSTEROIDS
5.3. ANTI-ACNE
5.4. CALCINEURIN INHIBITORS
5.5. RETINOIDS
5.6. OTHER DRUG CLASSES
6. MARKET BY APPLICATION
6.1. ALOPECIA
6.2. HERPES
6.3. PSORIASIS
6.4. ROSACEA
6.5. ATOPIC DERMATITIS
6.6. ACNE VULGARIS
6.7. OTHER APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANADA
7.2. EUROPE
7.2.1. UNITED KINGDOM
7.2.2. GERMANY
7.2.3. FRANCE
7.2.4. ITALY
7.2.5. RUSSIA
7.2.6. BELGIUM
7.2.7. POLAND
7.2.8. REST OF EUROPE
7.3. ASIA PACIFIC
7.3.1. CHINA
7.3.2. JAPAN
7.3.3. INDIA
7.3.4. SOUTH KOREA
7.3.5. INDONESIA
7.3.6. THAILAND
7.3.7. VIETNAM
7.3.8. AUSTRALIA & NEW ZEALAND
7.3.9. REST OF ASIA PACIFIC
7.4. REST OF WORLD
7.4.1. LATIN AMERICA
7.4.2. MIDDLE EAST & AFRICA
8. COMPANY PROFILES
8.1. ABBVIE INC
8.2. ALLERGAN INC
8.3. ALMIRAL
8.4. AMGEN INC
8.5. BAUSCH HEALTH COMPANIES INC
8.6. GALDERMA
8.7. GLAXOSMITHKLINE PLC
8.8. JOHNSON & JOHNSON
8.9. NOVARTIS AG
8.10. PFIZER INC
8.11. AGI DERMATICS
8.12. LEO PHARMA A/S
8.13. MERCK KGAA
TABLE 1: MARKET SNAPSHOT - DERMATOLOGICAL THERAPEUTICS
TABLE 2: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 3: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 4: GLOBAL ANTI-INFECTIVES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 5: GLOBAL ANTI-INFECTIVES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 6: GLOBAL CORTICOSTEROIDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 7: GLOBAL CORTICOSTEROIDS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 8: GLOBAL ANTI-ACNE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN BILLION)
TABLE 9: GLOBAL ANTI-ACNE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 10: GLOBAL CALCINEURIN INHIBITORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 11: GLOBAL CALCINEURIN INHIBITORS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 12: GLOBAL RETINOIDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 13: GLOBAL RETINOIDS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 14: GLOBAL OTHER DRUG CLASSES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 15: GLOBAL OTHER DRUG CLASSES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 16: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 17: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 18: GLOBAL ALOPECIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 19: GLOBAL ALOPECIA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 20: GLOBAL HERPES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 21: GLOBAL HERPES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 22: GLOBAL PSORIASIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 23: GLOBAL PSORIASIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 24: GLOBAL ROSACEA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 25: GLOBAL ROSACEA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 26: GLOBAL ATOPIC DERMATITIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 27: GLOBAL ATOPIC DERMATITIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 28: GLOBAL ACNE VULGARIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 29: GLOBAL ACNE VULGARIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 30: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 31: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 32: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 33: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 34: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 35: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 36: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 37: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 38: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 39: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 40: REST OF WORLD DERMATOLOGICAL THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 41: REST OF WORLD DERMATOLOGICAL THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2019-2028 (IN $ BILLION)
【免責事項】
https://www.marketreport.jp/reports-disclaimer